scholarly article | Q13442814 |
P50 | author | Robert E. W. Hancock | Q53441913 |
Linda Rehaume | Q56811126 | ||
P2093 | author name string | Robert S Hodges | |
Adriana I Vasil | |||
Michael L Vasil | |||
Jane L Burns | |||
Yuxin Chen | |||
Colin T Mant | |||
P2860 | cites work | Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? | Q29547675 |
Determination of stereochemistry stability coefficients of amino acid side-chains in an amphipathic alpha-helix. | Q30330002 | ||
Development of the structural basis for antimicrobial and hemolytic activities of peptides based on gramicidin S and design of novel analogs using NMR spectroscopy | Q30595444 | ||
Animal antimicrobial peptides: an overview | Q33638713 | ||
Reviving the antibiotic miracle? | Q72353506 | ||
Peptide antibiotics | Q73073957 | ||
A novel method to measure self-association of small amphipathic molecules: temperature profiling in reversed-phase chromatography | Q73246661 | ||
Relationship of sidechain hydrophobicity and alpha-helical propensity on the stability of the single-stranded amphipathic alpha-helix | Q73510301 | ||
Temperature profiling of polypeptides in reversed-phase liquid chromatography. I. Monitoring of dimerization and unfolding of amphipathic alpha-helical peptides | Q78753264 | ||
Temperature profiling of polypeptides in reversed-phase liquid chromatography. II. Monitoring of folding and stability of two-stranded alpha-helical coiled-coils | Q78753268 | ||
All-D amino acid-containing channel-forming antibiotic peptides | Q33643488 | ||
Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides | Q33789716 | ||
Antimicrobial peptide therapeutics for cystic fibrosis | Q33883742 | ||
Host-defense antimicrobial peptides: importance of structure for activity | Q34123205 | ||
The crisis in antibiotic resistance | Q34314442 | ||
Pseudomonal infection in cystic fibrosis: the battle continues | Q34358536 | ||
Antimicrobial peptides: premises and promises | Q34369795 | ||
Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index | Q34432501 | ||
Effects of single D-amino acid substitutions on disruption of beta-sheet structure and hydrophobicity in cyclic 14-residue antimicrobial peptide analogs related to gramicidin S. | Q34623545 | ||
Temperature selectivity in reversed-phase high performance liquid chromatography | Q34865944 | ||
Pseudomonas aeruginosa, Candida albicans, and device-related nosocomial infections: implications, trends, and potential approaches for control | Q36114466 | ||
Antimicrobial peptides: new candidates in the fight against bacterial infections | Q36120089 | ||
Current guidelines for the treatment of severe pneumonia and sepsis | Q36231604 | ||
Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options | Q36268383 | ||
Determination of intrinsic hydrophilicity/hydrophobicity of amino acid side chains in peptides in the absence of nearest-neighbor or conformational effects | Q37348516 | ||
Cystic fibrosis. 1. Pseudomonas aeruginosa infection in cystic fibrosis and its management | Q38007627 | ||
Lipids of mitochondria | Q38148540 | ||
Proton electrochemical gradient in Escherichia coli cells and its relation to active transport of lactose | Q39237347 | ||
N-Acylated and D enantiomer derivatives of a nonamer core peptide of lactoferricin B showing improved antimicrobial activity | Q39470734 | ||
Specificity of lipid-protein interactions as determined by spectroscopic techniques | Q39494730 | ||
Antimicrobial peptide magainin I from Xenopus skin forms anion-permeable channels in planar lipid bilayers | Q39622704 | ||
Electrically gated ionic channels in lipid bilayers | Q39625257 | ||
Molecular architecture and functioning of the outer membrane of Escherichia coli and other gram-negative bacteria | Q40144766 | ||
In vitro uptake and stability study of pVEC and its all-D analog | Q40652166 | ||
Cationic peptides: a new source of antibiotics | Q41714967 | ||
All-D-cecropin B: synthesis, conformation, lipopolysaccharide binding, and antibacterial activity | Q43593605 | ||
'Detergent-like' permeabilization of anionic lipid vesicles by melittin | Q43737327 | ||
Antimicrobial activity and stability to proteolysis of small linear cationic peptides with D-amino acid substitutions | Q44271454 | ||
Exploring peptide membrane interaction using surface plasmon resonance: differentiation between pore formation versus membrane disruption by lytic peptides | Q44276478 | ||
Structure–activity relationships of de novo designed cyclic antimicrobial peptides based on gramicidin S | Q44415329 | ||
Structure-activity relationships for the beta-hairpin cationic antimicrobial peptide polyphemusin I. | Q44889398 | ||
Optimum concentration of trifluoroacetic acid for reversed-phase liquid chromatography of peptides revisited | Q45022643 | ||
All-D-enantiomers of beta-amyloid exhibit similar biological properties to all-L-beta-amyloids. | Q46031773 | ||
Influence of gentamicin and tobramycin on binary biofilm formation by co-cultures of Burkholderia cepacia and Pseudomonas aeruginosa. | Q46723218 | ||
Determinants of recombinant production of antimicrobial cationic peptides and creation of peptide variants in bacteria | Q47907289 | ||
Influence of proline residues on the antibacterial and synergistic activities of alpha-helical peptides. | Q50518048 | ||
Interaction of antimicrobial dermaseptin and its fluorescently labeled analogues with phospholipid membranes | Q50787783 | ||
Dissociation of antimicrobial and hemolytic activities in cyclic peptide diastereomers by systematic alterations in amphipathicity. | Q52534879 | ||
Effect of D-amino acid substitution on the stability, the secondary structure, and the activity of membrane-active peptide. | Q52537084 | ||
D-cecropin B: proteolytic resistance, lethality for pathogenic fungi and binding properties. | Q52582319 | ||
P433 | issue | 2 | |
P921 | main subject | enantiomer | Q494483 |
antimicrobial peptide | Q1201508 | ||
P304 | page(s) | 162-173 | |
P577 | publication date | 2006-02-01 | |
P1433 | published in | Chemical Biology and Drug Design | Q15749458 |
P1476 | title | Comparison of biophysical and biologic properties of alpha-helical enantiomeric antimicrobial peptides | |
P478 | volume | 67 |
Q33584712 | "Specificity Determinants" Improve Therapeutic Indices of Two Antimicrobial Peptides Piscidin 1 and Dermaseptin S4 Against the Gram-negative Pathogens Acinetobacter baumannii and Pseudomonas aeruginosa |
Q34823180 | A D-peptide analog of the second extracellular loop of claudin-3 and -4 leads to mislocalized claudin and cellular apoptosis in mammary epithelial cells |
Q30847307 | A retro-inverso cell-penetrating peptide for siRNA delivery. |
Q37825833 | Alpha-helical cationic antimicrobial peptides: relationships of structure and function |
Q37424896 | An antibacterial and absorbable silk-based fixation material with impressive mechanical properties and biocompatibility |
Q35687730 | Anti-tuberculosis activity of α-helical antimicrobial peptides: de novo designed L- and D-enantiomers versus L- and D-LL-37. |
Q38920223 | Beyond conventional antibiotics - New directions for combination products to combat biofilm |
Q37778941 | Cationic amphiphiles, a new generation of antimicrobials inspired by the natural antimicrobial peptide scaffold |
Q48112477 | Co-administration of iRGD with peptide HPRP-A1 to improve anticancer activity and membrane penetrability |
Q44520859 | D-Cateslytin, a new antimicrobial peptide with therapeutic potential |
Q42318156 | D-form KLKLLLLLKLK-NH2 peptide exerts higher antimicrobial properties than its L-form counterpart via an association with bacterial cell wall components |
Q92219969 | De Novo Designed Amphipathic α-Helical Antimicrobial Peptides Incorporating Dab and Dap Residues on the Polar Face To Treat the Gram-Negative Pathogen, Acinetobacter baumannii |
Q39162082 | Design of potent, non-toxic anticancer peptides based on the structure of the antimicrobial peptide, temporin-1CEa |
Q33897986 | Discovery of a small peptide from combinatorial libraries that can activate the plant immune system by a jasmonic acid signaling pathway |
Q28478343 | Effect of BMAP-28 antimicrobial peptides on Leishmania major promastigote and amastigote growth: role of leishmanolysin in parasite survival |
Q92900106 | Effects of D-Lysine Substitutions on the Activity and Selectivity of Antimicrobial Peptide CM15 |
Q37313642 | Effects of hydrophobicity on the antifungal activity of alpha-helical antimicrobial peptides |
Q37385746 | Effects of net charge and the number of positively charged residues on the biological activity of amphipathic alpha-helical cationic antimicrobial peptides |
Q39202053 | Enhanced Antimicrobial Activity of AamAP1-Lysine, a Novel Synthetic Peptide Analog Derived from the Scorpion Venom Peptide AamAP1. |
Q34809662 | Evolution of antimicrobial peptides to self-assembled peptides for biomaterial applications |
Q54282937 | Functional synergy of α-helical antimicrobial peptides and traditional antibiotics against Gram-negative and Gram-positive bacteria in vitro and in vivo. |
Q56483985 | HPLC Analysis and Purification of Peptides |
Q44276923 | HPLC analysis and purification of peptides |
Q33926906 | Hydrophobicity and helicity regulate the antifungal activity of 14-helical β-peptides |
Q42251963 | Improved protease stability of the antimicrobial peptide Pin2 substituted with D-amino acids. |
Q92377294 | In silico design and optimization of selective membranolytic anticancer peptides |
Q42058965 | In vitro activities of synthetic host defense propeptides processed by neutrophil elastase against cystic fibrosis pathogens |
Q39788897 | Knowledge-based computational methods for identifying or designing novel, non-homologous antimicrobial peptides |
Q44385177 | Lipid-packing perturbation of model membranes by pH-responsive antimicrobial peptides |
Q42612783 | New linear antiplasmodial peptides related to angiotensin II. |
Q40266754 | Novel antimicrobial peptide CPF-C1 analogs with superior stabilities and activities against multidrug-resistant bacteria. |
Q41907555 | Novel method to identify the optimal antimicrobial peptide in a combination matrix, using anoplin as an example |
Q46628699 | Origin of low mammalian cell toxicity in a class of highly active antimicrobial amphipathic helical peptides |
Q92823732 | Peptide-Based Efflux Pump Inhibitors of the Small Multidrug Resistance Protein from Pseudomonas aeruginosa |
Q40185116 | Preliminary investigations into developing all-D Omiganan for treating Mupirocin-resistant MRSA skin infections. |
Q101137934 | Preparation, Characterization and Pharmacokinetic study of N-Terminal PEGylated D-form Antimicrobial Peptide OM19r-8 |
Q41897373 | Preparative reversed-phase high-performance liquid chromatography collection efficiency for an antimicrobial peptide on columns of varying diameters (1mm to 9.4mm I.D.). |
Q57056760 | Profiling antimicrobial peptides from the medical maggot Lucilia sericata as potential antibiotics for MDR Gram-negative bacteria |
Q34713859 | Rational design of α-helical antimicrobial peptides to target Gram-negative pathogens, Acinetobacter baumannii and Pseudomonas aeruginosa: utilization of charge, 'specificity determinants,' total hydrophobicity, hydrophobe type and location as desig |
Q57177969 | Retro-inversion enhances the adjuvant and CpG co-adjuvant activity of host defence peptide Bac2A |
Q42237870 | Role of helicity on the anticancer mechanism of action of cationic-helical peptides. |
Q35758832 | Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides |
Q48242962 | Role of positively charged residues on the polar and non-polar faces of amphipathic α-helical antimicrobial peptides on specificity and selectivity for Gram-negative pathogens. |
Q57177960 | Stability, toxicity, and biological activity of host defense peptide BMAP28 and its inversed and retro-inversed isomers |
Q35017565 | Structure-guided RP-HPLC chromatography of diastereomeric α-helical peptide analogs substituted with single amino acid stereoisomers |
Q38964531 | Synthesis of composites SBA-15 mesoporous particles carrying oxytocin and evaluation of their properties, functions, and in vitro biological activities |
Q47118800 | Synthetic host defense peptide IDR-1002 reduces inflammation in Pseudomonas aeruginosa lung infection |
Q35905605 | The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace |
Q37954604 | The potential of antimicrobial peptides as biocides |
Q53473484 | Tryptophan as a probe to study the anticancer mechanism of action and specificity of α-helical anticancer peptides. |
Search more.